Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency

Iron-deficiency Clinical Trial

— CarenceMartial  

Official title:

Accordance Between Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency, in Patients Hospitalised in Internal Medicine Service and 65 Years Old and More

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04139265
• Other study ID #: RC-P0079
• Status: Completed
• Start date: June 6, 2019
• Est. completion date: September 30, 2019

Study information

• Verified date: October 2019
• Source: Lille Catholic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Transferrin saturation coefficient and ferritinemia in diagnosis of iron deficiency

Recruitment information / eligibility

• Status: Completed
• Enrollment: 136
• Est. completion date: September 30, 2019
• Est. primary completion date: September 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• = 65 years old

• Patient hospitalized in the internal medicine and geriatry service

• Patient affiliated with a social security scheme

• Patient signed an Informed consent

Exclusion Criteria:

• Risk benefit balance not in favor of iron deficiency check-up

• Patient in palliative care

Related Conditions & MeSH terms

• Anemia, Iron-Deficiency
• Ferritinemia
• Internal Medicine
• Iron-deficiency
• Transferrin

Intervention

Diagnostic Test:
• biologic analysis (ferritinemia, transferrin saturation coefficient)
Each patient will follow a blood test in order to compare between ferritinemia and transferrin saturation coefficient in iron deficiency diagnosis

Locations

Country	Name	City	State
France	Saint-Philibert hospital	Lomme	Nord

Sponsors (1)

Lead Sponsor	Collaborator
Lille Catholic University

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Agreement between Transferrin Saturation Coefficient (TSC) and ferritinemia dosage	The overall agreement, assessed by kappa Cohen	Day one
Secondary	Prevalence of iron deficiency with and without anaemia	Number of patients with iron deficiency with or without anaemia	Day one
Secondary	Prevalence of etiologies of iron deficiency	Number of patients for each etiology	Day one
Secondary	Prevalence of iron deficiency in patients with anticoagulant and platelet aggregation inhibitor		Day one